Dissolvable heart scaffold could replace permanent stents in major trial
NCT ID NCT07022587
First seen Feb 16, 2026 · Last updated May 08, 2026 · Updated 14 times
Summary
This study compares a new dissolvable scaffold (Firesorb) to a standard metal stent for treating blocked heart arteries. The scaffold is designed to support the artery temporarily and then dissolve, potentially avoiding long-term problems linked to permanent stents. About 2,000 people with coronary artery disease will be randomly assigned to receive either device. The main goal is to see if the scaffold works as well as the stent at preventing heart-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xijing Hospital
RECRUITINGXi'an, Shannxi, 710032, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.